Leonardo Barbosa Almeida1, Mateus Camaroti Laterza2, Maria Urbana Pinto Brandão Rondon3, Luciana Diniz Nagem Janot de Matos4, Catherine L Granger5, Linda Denehy5, Cristino Carneiro Oliveira6, Patricia Fernandes Trevizan2, Daniel Godoy Martinez2. 1. Cardiovascular Research Unit and Exercise Physiology, Federal University of Juiz de Fora, José Lourenço Kelmer, s/n, Martelos, Juiz de Fora, 36036-900, Brazil. almeidalb@hotmail.com. 2. Cardiovascular Research Unit and Exercise Physiology, Federal University of Juiz de Fora, José Lourenço Kelmer, s/n, Martelos, Juiz de Fora, 36036-900, Brazil. 3. School of Physical Education and Sport, University of São Paulo, São Paulo, Brazil. 4. Hospital Israelita Albert Einstein, São Paulo, Brazil. 5. Department of Physiotherapy, University of Melbourne, Melbourne, Australia. 6. Postgraduate Research Program On Rehabilitation Sciences and Physical Function Performance, Federal University of Juiz de Fora, Juiz de Fora, Brazil.
Abstract
PURPOSE: To investigate the effect of inspiratory muscle training (IMT) in addition to conventional physical rehabilitation on muscle strength, functional capacity, mobility, hemodynamics, fatigue, and quality of life in hospitalized patients undergoing hematopoietic stem cell transplantation (HSCT). METHODS: We conducted a randomized controlled trial in 57 inpatients with hematological diseases undergoing HSCT. Conventional inpatient physical rehabilitation was delivered to the IMT (n = 27) and control (CON; n = 30) groups according to usual care, and the first group additionally performed IMT. The IMT was prescribed according to clinical and laboratory parameters at 40% of maximal inspiratory pressure (MIP), 5 days/week throughout the hospitalization, in sessions of 10-20 min. The primary outcome was MIP and the secondary outcomes were maximal expiratory pressure (MEP), peripheral muscle strength (handgrip and sit-to-stand tests), functional capacity (6-min step test), mobility (timed up and go test), blood pressure, quality of life (EORTC-QLQ-C30), and fatigue (FACT-F) at admission and hospital discharge. RESULTS: The population was predominately autologous HSCT. The IMT group significantly increased the MIP (P < 0.01) and decreased both fatigue (P = 0.01) and blood pressure (P < 0.01) compared with control. No differences were found between admission and hospital discharge in peripheral and expiratory muscle strength, functional capacity, mobility, and quality of life in both groups (P > 0.05). CONCLUSIONS: Our results support the effectiveness of IMT as part of rehabilitation for HSCT inpatients, improving inspiratory muscle strength, and reducing fatigue and blood pressure. TRIAL REGISTRATION: NCT03373526 (clinicaltrials.gov).
PURPOSE: To investigate the effect of inspiratory muscle training (IMT) in addition to conventional physical rehabilitation on muscle strength, functional capacity, mobility, hemodynamics, fatigue, and quality of life in hospitalized patients undergoing hematopoietic stem cell transplantation (HSCT). METHODS: We conducted a randomized controlled trial in 57 inpatients with hematological diseases undergoing HSCT. Conventional inpatient physical rehabilitation was delivered to the IMT (n = 27) and control (CON; n = 30) groups according to usual care, and the first group additionally performed IMT. The IMT was prescribed according to clinical and laboratory parameters at 40% of maximal inspiratory pressure (MIP), 5 days/week throughout the hospitalization, in sessions of 10-20 min. The primary outcome was MIP and the secondary outcomes were maximal expiratory pressure (MEP), peripheral muscle strength (handgrip and sit-to-stand tests), functional capacity (6-min step test), mobility (timed up and go test), blood pressure, quality of life (EORTC-QLQ-C30), and fatigue (FACT-F) at admission and hospital discharge. RESULTS: The population was predominately autologous HSCT. The IMT group significantly increased the MIP (P < 0.01) and decreased both fatigue (P = 0.01) and blood pressure (P < 0.01) compared with control. No differences were found between admission and hospital discharge in peripheral and expiratory muscle strength, functional capacity, mobility, and quality of life in both groups (P > 0.05). CONCLUSIONS: Our results support the effectiveness of IMT as part of rehabilitation for HSCT inpatients, improving inspiratory muscle strength, and reducing fatigue and blood pressure. TRIAL REGISTRATION: NCT03373526 (clinicaltrials.gov).
Authors: J van der Palen; T D Rea; T A Manolio; T Lumley; A B Newman; R P Tracy; P L Enright; B M Psaty Journal: Thorax Date: 2004-12 Impact factor: 9.139
Authors: W A Wood; A M Deal; B B Reeve; A P Abernethy; E Basch; S A Mitchell; C Shatten; Y Hie Kim; J Whitley; J S Serody; T Shea; C Battaglini Journal: Bone Marrow Transplant Date: 2013-04-15 Impact factor: 5.483
Authors: Paul J Martin; George W Counts; Frederick R Appelbaum; Stephanie J Lee; Jean E Sanders; H Joachim Deeg; Mary E D Flowers; Karen L Syrjala; John A Hansen; Rainer F Storb; Barry E Storer Journal: J Clin Oncol Date: 2010-01-11 Impact factor: 44.544
Authors: Jessica M Scott; Saro Armenian; Sergio Giralt; Javid Moslehi; Thomas Wang; Lee W Jones Journal: Crit Rev Oncol Hematol Date: 2015-11-17 Impact factor: 6.312
Authors: Ana Luiza Machado Dias; Mateus Camaroti Laterza; Pedro Augusto de Carvalho Mira; Isabelle Magalhães Guedes Freitas; Patrícia Fernandes Trevizan; Daniel Godoy Martinez; Leonardo Barbosa de Almeida Journal: Support Care Cancer Date: 2020-11-27 Impact factor: 3.603